Perceptron, Inc. (NASDAQ:PRCP) Director John F. Bryant purchased 482,991 shares of the business’s stock in a transaction that occurred on Thursday, June 13th. The stock was purchased at an average price of $4.75 per share, for a total transaction of $2,294,207.25. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.
Shares of PRCP traded down $0.08 during mid-day trading on Friday, hitting $4.06. 27,008 shares of the company’s stock were exchanged, compared to its average volume of 16,914. The firm has a market capitalization of $39.82 million, a P/E ratio of 10.41 and a beta of 1.01. Perceptron, Inc. has a 52 week low of $4.03 and a 52 week high of $12.00. The stock has a 50-day moving average of $4.46.
Perceptron (NASDAQ:PRCP) last released its quarterly earnings data on Thursday, May 9th. The scientific and technical instruments company reported ($0.11) EPS for the quarter, missing the consensus estimate of $0.02 by ($0.13). The company had revenue of $15.63 million during the quarter, compared to analyst estimates of $18.40 million. Perceptron had a net margin of 2.61% and a return on equity of 3.45%. Equities research analysts predict that Perceptron, Inc. will post 0.13 EPS for the current fiscal year.PRCP has been the subject of a number of research reports. ValuEngine cut Yext from a “strong-buy” rating to a “buy” rating in a research note on Friday, May 10th. B. Riley set a $13.00 price target on shares of Audioeye and gave the stock a “buy” rating in a research note on Monday, May 13th. TheStreet raised shares of SUMMIT THERAPEU/S from a “d” rating to a “c-” rating in a research note on Thursday, June 13th. Finally, Zacks Investment Research cut shares of G1 Therapeutics from a “buy” rating to a “hold” rating in a research note on Thursday, May 16th.
Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Quantum Capital Management boosted its holdings in shares of Perceptron by 14.9% in the 4th quarter. Quantum Capital Management now owns 137,877 shares of the scientific and technical instruments company’s stock valued at $1,124,000 after buying an additional 17,887 shares during the last quarter. Penbrook Management LLC boosted its holdings in shares of Perceptron by 8.7% in the 1st quarter. Penbrook Management LLC now owns 173,993 shares of the scientific and technical instruments company’s stock valued at $1,305,000 after buying an additional 13,950 shares during the last quarter. Finally, Punch & Associates Investment Management Inc. boosted its holdings in shares of Perceptron by 3.4% in the 1st quarter. Punch & Associates Investment Management Inc. now owns 585,644 shares of the scientific and technical instruments company’s stock valued at $4,392,000 after buying an additional 19,060 shares during the last quarter. 71.20% of the stock is owned by institutional investors.
Perceptron, Inc develops, produces, and sells various automated industrial metrology products and solutions to manufacturing organizations for dimensional gauging, dimensional inspection, and 3D scanning in Europe, Asia, and the Americas. It provides various in-line and near-line measurement solutions, including AutoGauge, AutoGauge ACF, AutoGuide, and Helix evo engineered metrology systems for industrial automated process control and assembly using fixed and robot mounted laser scanners; and offline measurement solutions comprising Coord3 and TouchDMIS for industrial gauging and dimensional inspection using standalone robot mounted laser scanners and coordinate measuring machines.
Featured Article: Why is the Consumer Price Index (CPI) important?
Receive News & Ratings for Perceptron Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Perceptron and related companies with MarketBeat.com’s FREE daily email newsletter.